Results 131 to 140 of about 7,787,676 (175)

HPV (human papillomavirus) vaccine : what you need to know [Russian]

HPV (human papillomavirus) vaccine : what you need to know [Russian]HPV VIS \u2013 Russian (8/6/21)russian_hpv ...

core  

Decreases in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers: HPV-IMPACT, 2008 to 2019. [PDF]

Cancer Epidemiol Biomarkers Prev
Stefanos R, Gargano JW, Niccolai LM, Castilho JL, Park IU, Bostick EA, Ehlers S, Blankenship S, Brackney MM, Chan K, Kurtz R, Whitney E, Moritz RE, Vigar MK, Querec TD, Unger ER, Markowitz LE, HPV-IMPACT Working Group.   +17 more
europepmc   +1 more source

HPV (human papillomavirus) vaccine : what you need to know [Spanish]

HPV (human papillomavirus) vaccine : what you need to know [Spanish]HPV VIS \u2013 Spanish (8/6/21)spanish_hpv ...

core  

Prevalence and determinants of human papillomavirus vaccine hesitancy among parents of young girls in Morocco. [PDF]

Sci Rep
Essayagh T, Essayagh M, Lemriss H, Mourad R, Nmila K, Slibani H, Hachimi SE, Boukhari ME, Addakiri K, Zadran R, Tigaidi H, Lemriss S, Essayagh S.   +12 more
europepmc   +1 more source

HPV (human papillomavirus) vaccine : what you need to know [Vietnamese]

HPV (human papillomavirus) vaccine : what you need to know [Vietnamese]HPV VIS \u2013 Vietnamese (8/6/21)vietnamese_hpv ...

core  

Uptake of human papillomavirus vaccine among school girls and its associated factors in Addis Ababa, Ethiopia. [PDF]

SAGE Open Med
Haile AF, Berhane Y.
europepmc   +1 more source

Human Papillomavirus Vaccine Intent and Associated Factors Among the Unvaccinated University Freshmen in the Largest University Town in China. [PDF]

Vaccines (Basel)
Yao H, Lu H, Zhu Q, Shen J, Fu X, Lu Y.
europepmc   +1 more source

Assessment of the impact of nonavalent human papillomavirus vaccine on disease clearance time in women with active infection. [PDF]

Rev Bras Ginecol Obstet
Grillo N, Almendra R, Correia C.
europepmc   +1 more source

Perceived facilitators and barriers against human papillomavirus vaccine among rural parents with eligible daughters in the Alle district, Southern Ethiopia. [PDF]

PLoS One
Zenebe S, Yeheyis T, Tadesse F, Deribe B, Geresu G, Kasse T, Unverzagt S, Kroeber ES, Kantelhardt EJ, Taylor L, Ferrell B.   +10 more
europepmc   +1 more source

Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study. [PDF]

Front Public Health
Olubayo GT, Bakare A, Salako J, Olufayo OE, Bakare AA.   +4 more
europepmc   +1 more source